Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients | Zendy

Diane Descamps | Zendy; Sidonie Lambert-Niclot | Zendy; AnneGeneviève Marcelin | Zendy; Gilles Peytavin | Zendy; Bénédicte Roquebert | Zendy; Christine Katlama | Zendy; P. Yéni | Zendy; Mathieu Felices | Zendy; Vincent Cálvez | Zendy; Françoise BrunVézinet | Zendy

Open Access

Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients

Author(s) -

Diane Descamps,

Sidonie Lambert-Niclot,

AnneGeneviève Marcelin,

Gilles Peytavin,

Bénédicte Roquebert,

Christine Katlama,

P. Yéni,

Mathieu Felices,

Vincent Cálvez,

Françoise BrunVézinet

Publication year - 2009

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkn544

Subject(s) - darunavir , enfuvirtide , ritonavir , viral load , virology , protease inhibitor (pharmacology) , regimen , medicine , biology , drug resistance , resistance mutation , immunology , virus , gp41 , microbiology and biotechnology , gene , polymerase chain reaction , genetics , antiretroviral therapy , reverse transcriptase , antigen , epitope

The aim of the study was to identify a pattern of protease gene mutations associated with the virological response to darunavir/ritonavir-based regimens.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research